Melissa R. Gertler AssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail424-288-5314 Professional Biography Melissa Gertler is an associate in the Corporate Practice Group in the firm's Century City office. More Legal and Business Bylines From Melissa R. Gertler Elijah E. Cummins Lower Drug Costs Now Act: The Long and Winding Road to Drug Pricing Reform - (Posted On Wednesday, September 22, 2021) The Infrastructure Investment and Jobs Act: Potential Impact on Healthcare Policy and Spending - (Posted On Tuesday, August 24, 2021) Biden’s American Rescue Plan Follows Trend Toward Outpatient Setting, Increase in ASC Investment - (Posted On Thursday, May 20, 2021) Medi-Cal Rx: California to Transition Medi-Cal Pharmacy Benefits to Fee-For-Service - (Posted On Monday, January 11, 2021) CMS Announces New Geographic Direct Contracting Model: Letters of Interest Due by December 21, 2020 - (Posted On Tuesday, December 08, 2020) Eleventh Hour Rulemaking: HHS Eliminates Safe Harbor Protections for PBM Drug Rebates; and Creates Two New Safe Harbors for Point-of-Service Discounts and PBM Fixed-Fee Arrangements - (Posted On Wednesday, December 02, 2020) Texas v. California: SCOTUS Hears Oral Arguments About the Constitutionality of the ACA - (Posted On Tuesday, November 17, 2020) Primary Care First: CMS’s New Value-Based Approach to Primary Care - (Posted On Wednesday, November 11, 2020) The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry - (Posted On Friday, September 18, 2020) President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism - (Posted On Wednesday, August 19, 2020) Pagination Page 1 Next page Next › Current Legal Analysis NOT SO RAD: Repeat TCPA Litigator Ethan Radvansky Looks To Make His Mark With Three New Class Action Filings This Week by: Eric J. Troutman End of (Fund) Life Issues by: Margaret A Dale , Michael R. Hackett FDA Warning Letter Takes Issue with Designation of Substance as Dietary Ingredient by: Food and Drug Law at Keller and Heckman Understanding Small Business Size and Status Protests and Appeals: A Guide for Government Contractors by: Aron C. Beezley , Gabrielle A. Sprio Nebraska to Restrict SNAP Soda and Energy Drink Purchases by: Food and Drug Law at Keller and Heckman CPSC Withdraws Lithium-Ion Battery Rulemaking by: Sheila A. Millar , Antonia Stamenova-Dancheva Should Nevada Corporations Say Goodbye To Ratification Of Auditor Appointments? by: Keith Paul Bishop FTC Delays Enforcement of Click-to-Cancel Rule by: Sheila A. Millar , Antonia Stamenova-Dancheva Court of Appeals Ruling in Nellenback Provides CVA Clarity by: Gary J. Intoccia PTAB Rejects AI-Driven Medical Patent – Not for Novelty, But Eligibility by: James W. Soong Department of Energy Announces Initiative to Review the Agency’s Federal Awards by: Robert J. Wagman, Jr. , Nicole Boeckmann Changes in Migratory Bird Treaty Act Protections – Impacts on Project Development by: Ana Maria Gutierrez , Jessica Portmess Considerations for Life Sciences Employers When Planning Reductions in Force by: Mark H. Burak , David J.B. Froiland Clawback Enforcement Under SEC Rule 10D-1 by: Matthew R. Zischke The Trump Administration Announces Price Targets as It Takes a Second Swing at “Most Favored Nation” Drug Pricing Model by: Claire Davies , Suzanne E. Bassett Upcoming Events May 22 2025 Kidd Aitken & Chambers USA Q&A May 22 2025 Yours, Mine, or Ours? The Complex and Often Competing Duties Owed by Agents and Brokers to Their Insurers and Insureds May 22 2025 A Practical Understanding of Intellectual Property May 27 2025 Making a Mountain Out of a Mole Hill: Damage Escalation Strategies in Property Claims Print
